Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 412
Filter
2.
Neurosci Biobehav Rev ; 161: 105649, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38579902

ABSTRACT

With dementia incidence projected to escalate significantly within the next 25 years, the United Nations declared 2021-2030 the Decade of Healthy Ageing, emphasising cognition as a crucial element. As a leading discipline in cognition and ageing research, psychology is well-equipped to offer insights for translational research, clinical practice, and policy-making. In this comprehensive review, we discuss the current state of knowledge on age-related changes in cognition and psychological health. We discuss cognitive changes during ageing, including (a) heterogeneity in the rate, trajectory, and characteristics of decline experienced by older adults, (b) the role of cognitive reserve in age-related cognitive decline, and (c) the potential for cognitive training to slow this decline. We also examine ageing and cognition through multiple theoretical perspectives. We highlight critical unresolved issues, such as the disparate implications of subjective versus objective measures of cognitive decline and the insufficient evaluation of cognitive training programs. We suggest future research directions, and emphasise interdisciplinary collaboration to create a more comprehensive understanding of the factors that modulate cognitive ageing.


Subject(s)
Cognition , Healthy Aging , Humans , Healthy Aging/physiology , Healthy Aging/psychology , Cognition/physiology , Cognitive Dysfunction/physiopathology , Cognitive Reserve/physiology , Aging/physiology , Cognitive Aging/physiology
3.
Hum Brain Mapp ; 45(6): e26687, 2024 Apr 15.
Article in English | MEDLINE | ID: mdl-38651629

ABSTRACT

The unprecedented increase in life expectancy presents a unique opportunity and the necessity to explore both healthy and pathological aspects of ageing. Electroencephalography (EEG) has been widely used to identify neuromarkers of cognitive ageing due to its affordability and richness in information. However, despite the growing volume of data and methodological advancements, the abundance of contradictory and non-reproducible findings has hindered clinical translation. To address these challenges, our study introduces a comprehensive workflow expanding on previous EEG studies and investigates various static and dynamic power and connectivity estimates as potential neuromarkers of cognitive ageing in a large dataset. We also assess the robustness of our findings by testing their susceptibility to band specification. Finally, we characterise our findings using functionally annotated brain networks to improve their interpretability and multi-modal integration. Our analysis demonstrates the effect of methodological choices on findings and that dynamic rather than static neuromarkers are not only more sensitive but also more robust. Consequently, they emerge as strong candidates for cognitive ageing neuromarkers. Moreover, we were able to replicate the most established EEG findings in cognitive ageing, such as alpha oscillation slowing, increased beta power, reduced reactivity across multiple bands, and decreased delta connectivity. Additionally, when considering individual variations in the alpha band, we clarified that alpha power is characteristic of memory performance rather than ageing, highlighting its potential as a neuromarker for cognitive ageing. Finally, our approach using functionally annotated source reconstruction allowed us to provide insights into domain-specific electrophysiological mechanisms underlying memory performance and ageing. HIGHLIGHTS: We provide an open and reproducible pipeline with a comprehensive workflow to investigate static and dynamic EEG neuromarkers. Neuromarkers related to neural dynamics are sensitive and robust. Individualised alpha power characterises cognitive performance rather than ageing. Functional annotation allows cross-modal interpretation of EEG findings.


Subject(s)
Electroencephalography , Healthy Aging , Humans , Electroencephalography/methods , Healthy Aging/physiology , Aged , Male , Adult , Female , Middle Aged , Young Adult , Cognitive Aging/physiology , Biomarkers , Nerve Net/physiology , Brain Waves/physiology , Alpha Rhythm/physiology , Memory/physiology , Aging/physiology , Aged, 80 and over
5.
Neurobiol Aging ; 139: 82-89, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38657394

ABSTRACT

Alterations in grey matter (GM) and white matter (WM) are associated with memory impairment across the neurocognitive aging spectrum and theorised to spread throughout brain networks. Functional and structural connectivity (FC,SC) may explain widespread atrophy. We tested the effect of SC and FC to the hippocampus on cortical thickness (CT) of connected areas. In 419 (223 F) participants (agemean=73 ±â€¯8) from the Alzheimer's Disease Neuroimaging Initiative, cortical regions associated with memory (Rey Auditory Verbal Learning Test) were identified using Lasso regression. Two structural equation models (SEM), for SC and resting-state FC, were fitted including CT areas, and SC and FC to the left and right hippocampus (LHIP,RHIP). LHIP (ß=-0.150,p=<.001) and RHIP (ß=-0.139,p=<.001) SC predicted left temporopolar/rhinal CT; RHIP SC predicted right temporopolar/rhinal CT (ß=-0.191,p=<.001). LHIP SC predicted right fusiform/parahippocampal (ß=-0.104,p=.011) and intraparietal sulcus/superior parietal CT (ß=0.101,p=.028). Increased RHIP FC predicted higher left inferior parietal CT (ß=0.132,p=.042) while increased LHIP FC predicted lower right fusiform/parahippocampal CT (ß=-0.97; p=.023). The hippocampi may be epicentres for cortical thinning through disrupted connectivity.


Subject(s)
Cognitive Aging , Hippocampus , Humans , Aged , Male , Female , Hippocampus/diagnostic imaging , Hippocampus/pathology , Cognitive Aging/physiology , Aged, 80 and over , Memory/physiology , Magnetic Resonance Imaging , White Matter/diagnostic imaging , White Matter/pathology , Cerebral Cortical Thinning/diagnostic imaging , Cerebral Cortical Thinning/pathology , Gray Matter/diagnostic imaging , Gray Matter/pathology , Atrophy , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Aging/pathology , Aging/physiology , Aging/psychology , Nerve Net/diagnostic imaging , Nerve Net/pathology , Nerve Net/physiopathology
6.
Integr Psychol Behav Sci ; 58(2): 483-501, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38279076

ABSTRACT

Cognition is a mental process that provides the ability to think, know, and learn. Though cognitive skills are necessary to do daily tasks and activities, cognitive aging causes changes in various cognitive functions. Cognitive abilities that are preserved and strengthened by experience can be kept as a reserve and utilized when necessary. The concept of reserving cognition was found when people with Alzheimer's disease had differences in clinical manifestations and cognitive functions. The cognitive reserve builds resilience against cognitive decline and improves the quality of life. Also, several lines of studies have found that the plasticity between neurons has a significant impact on cognitive reserve and acts against cognitive decline. To extend the findings, the present study provides a comprehensive understanding of cognitive reserve and the variables that are involved in maintaining cognition. The study also considers reading as one of the cognitive proxies that develops and maintains cognitive reserve.


Subject(s)
Cognition , Cognitive Reserve , Humans , Cognitive Reserve/physiology , Cognition/physiology , Cognitive Dysfunction , Cognitive Aging/physiology , Reading , Aging/psychology , Aging/physiology , Alzheimer Disease/psychology
7.
Int J Psychiatry Clin Pract ; 28(1): 27-34, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38145312

ABSTRACT

OBJECTIVES: To study (i) the prevalence of mild and moderate-to-severe depressive symptoms in the entire spectrum of cognitive ageing in Greece and (ii) the relationship between these symptoms and demographic and clinical data. METHODS: The study was based on the randomly selected cohort of the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD). Depressive symptoms were assessed with the 15-item version of the Geriatric Depression Scale. Participants also received a comprehensive neuropsychological assessment, while the clinical diagnoses of dementia and mild cognitive impairment were established according to international diagnostic criteria. Statistical analyses relied on comparison tests and a logistic (proportional odds) ordinal regression model. RESULTS: Depressive symptoms were detected in 19.5% of the 1936 study participants, while 11.3% of both people with MCI and dementia had moderate-to-severe depressive symptoms. The regression model revealed that older adults with more severe depressive symptoms were more likely female, cognitively impaired, less educated, were treated with psychotropic medication and lived in Attica versus Thessaly. CONCLUSIONS: Since depressive symptoms were detected in almost one in five older adults, healthcare professionals in Greece should safeguard the timely detection and effective treatment of such symptoms and the post-diagnostic care of older adults with depression.


Depressive symptoms are present in approximately 20% of older adults.More than 10% of older individuals with dementia or mild cognitive impairment report moderate-to-severe depressive symptoms.Female sex, lower education, lower cognitive performance, living in urban areas and treatment with psychotropic medication pertain to more severe depressive symptoms in ageing.Timely detection and effective treatment of depressive symptoms are crucial in the clinical practice of the care of older adults.Further research is needed in order to elucidate the complex relationship between depressive symptoms and cognitive impairment in ageing.


Subject(s)
Cognitive Dysfunction , Depression , Humans , Greece/epidemiology , Female , Male , Aged , Longitudinal Studies , Depression/epidemiology , Cognitive Dysfunction/epidemiology , Cognitive Dysfunction/etiology , Aged, 80 and over , Dementia/epidemiology , Cognitive Aging/physiology , Middle Aged , Prevalence , Aging/physiology
8.
J Alzheimers Dis ; 93(4): 1457-1469, 2023.
Article in English | MEDLINE | ID: mdl-37212095

ABSTRACT

BACKGROUND: Discovering patterns of cognitive domains and characterizing how these patterns associate with other risk factors and biomarkers can improve our understanding of the determinants of cognitive aging. OBJECTIVE: To discover patterns of cognitive domains using neuropsychological test results in Long Life Family Study (LLFS) and characterize how these patterns associate with aging markers. METHODS: 5,086 LLFS participants were administered neuropsychological tests at enrollment. We performed a cluster analysis of six baseline neuropsychological test scores and tested the association between the identified clusters and various clinical variables, biomarkers, and polygenic risk scores using generalized estimating equations and the Chi-square test. We used Cox regression to correlate the clusters with the hazard of various medical events. We investigated whether the cluster information could enhance the prediction of cognitive decline using Bayesian beta regression. RESULTS: We identified 12 clusters with different cognitive signatures that represent profiles of performance across multiple neuropsychological tests. These signatures significantly correlated with 26 variables including polygenic risk scores, physical and pulmonary functions, and blood biomarkers and were associated with the hazard of mortality (p < 0.01), cardiovascular disease (p = 0.03), dementia (p = 0.01), and skin cancer (p = 0.03). CONCLUSION: The identified cognitive signatures capture multiple domains simultaneously and provide a holistic vision of cognitive function, showing that different patterns of cognitive function can coexist in aging individuals. Such patterns can be used for clinical intervention and primary care.


Subject(s)
Cluster Analysis , Cognitive Aging , Family Health , Longevity , Neuropsychological Tests , Aged, 80 and over , Female , Humans , Male , Bayes Theorem , Biomarkers , Cardiovascular Diseases , Cognition/physiology , Cognitive Aging/physiology , Cognitive Aging/psychology , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/psychology , Dementia , Holistic Health , Multifactorial Inheritance , Neuropsychological Tests/statistics & numerical data , Skin Neoplasms , Aged , Middle Aged
9.
Aging Cell ; 22(3): e13780, 2023 03.
Article in English | MEDLINE | ID: mdl-36644807

ABSTRACT

The contribution of cellular senescence to the behavioral changes observed in the elderly remains elusive. Here, we observed that aging is associated with a decline in protein phosphatase 2A (PP2A) activity in the brains of zebrafish and mice. Moreover, drugs activating PP2A reversed age-related behavioral changes. We developed a transgenic zebrafish model to decrease PP2A activity in the brain through knockout of the ppp2r2c gene encoding a regulatory subunit of PP2A. Mutant fish exhibited the behavioral phenotype observed in old animals and premature accumulation of neural cells positive for markers of cellular senescence, including senescence-associated ß-galactosidase, elevated levels cdkn2a/b, cdkn1a, senescence-associated secretory phenotype gene expression, and an increased level of DNA damage signaling. The behavioral and cell senescence phenotypes were reversed in mutant fish through treatment with the senolytic ABT263 or diverse PP2A activators as well as through cdkn1a or tp53 gene ablation. Senomorphic function of PP2A activators was demonstrated in mouse primary neural cells with downregulated Ppp2r2c. We conclude that PP2A reduction leads to neural cell senescence thereby contributing to age-related behavioral changes and that PP2A activators have senotherapeutic properties against deleterious behavioral effects of brain aging.


Subject(s)
Behavior, Animal , Brain , Cellular Senescence , Cognitive Aging , Neurons , Protein Phosphatase 2 , Senotherapeutics , Animals , Mice , Aniline Compounds/pharmacology , Animals, Genetically Modified , Behavior, Animal/drug effects , Behavior, Animal/physiology , beta-Galactosidase/genetics , beta-Galactosidase/metabolism , Biomarkers/metabolism , Brain/enzymology , Cellular Senescence/drug effects , Cellular Senescence/genetics , Cellular Senescence/physiology , Cognitive Aging/physiology , Cyclin-Dependent Kinase Inhibitor p15/genetics , Cyclin-Dependent Kinase Inhibitor p15/metabolism , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , DNA Damage , Gene Expression Regulation , Gene Knockout Techniques , Models, Animal , Mutation , Neurons/drug effects , Neurons/enzymology , Neurons/physiology , Primary Cell Culture , Protein Phosphatase 2/genetics , Protein Phosphatase 2/metabolism , Senotherapeutics/pharmacology , Sulfonamides/pharmacology , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Zebrafish
10.
JAMA ; 328(22): 2218-2229, 2022 12 13.
Article in English | MEDLINE | ID: mdl-36511926

ABSTRACT

Importance: Episodic memory and executive function are essential aspects of cognitive functioning that decline with aging. This decline may be ameliorable with lifestyle interventions. Objective: To determine whether mindfulness-based stress reduction (MBSR), exercise, or a combination of both improve cognitive function in older adults. Design, Setting, and Participants: This 2 × 2 factorial randomized clinical trial was conducted at 2 US sites (Washington University in St Louis and University of California, San Diego). A total of 585 older adults (aged 65-84 y) with subjective cognitive concerns, but not dementia, were randomized (enrollment from November 19, 2015, to January 23, 2019; final follow-up on March 16, 2020). Interventions: Participants were randomized to undergo the following interventions: MBSR with a target of 60 minutes daily of meditation (n = 150); exercise with aerobic, strength, and functional components with a target of at least 300 minutes weekly (n = 138); combined MBSR and exercise (n = 144); or a health education control group (n = 153). Interventions lasted 18 months and consisted of group-based classes and home practice. Main Outcomes and Measures: The 2 primary outcomes were composites of episodic memory and executive function (standardized to a mean [SD] of 0 [1]; higher composite scores indicate better cognitive performance) from neuropsychological testing; the primary end point was 6 months and the secondary end point was 18 months. There were 5 reported secondary outcomes: hippocampal volume and dorsolateral prefrontal cortex thickness and surface area from structural magnetic resonance imaging and functional cognitive capacity and self-reported cognitive concerns. Results: Among 585 randomized participants (mean age, 71.5 years; 424 [72.5%] women), 568 (97.1%) completed 6 months in the trial and 475 (81.2%) completed 18 months. At 6 months, there was no significant effect of mindfulness training or exercise on episodic memory (MBSR vs no MBSR: 0.44 vs 0.48; mean difference, -0.04 points [95% CI, -0.15 to 0.07]; P = .50; exercise vs no exercise: 0.49 vs 0.42; difference, 0.07 [95% CI, -0.04 to 0.17]; P = .23) or executive function (MBSR vs no MBSR: 0.39 vs 0.31; mean difference, 0.08 points [95% CI, -0.02 to 0.19]; P = .12; exercise vs no exercise: 0.39 vs 0.32; difference, 0.07 [95% CI, -0.03 to 0.18]; P = .17) and there were no intervention effects at the secondary end point of 18 months. There was no significant interaction between mindfulness training and exercise (P = .93 for memory and P = .29 for executive function) at 6 months. Of the 5 prespecified secondary outcomes, none showed a significant improvement with either intervention compared with those not receiving the intervention. Conclusions and Relevance: Among older adults with subjective cognitive concerns, mindfulness training, exercise, or both did not result in significant differences in improvement in episodic memory or executive function at 6 months. The findings do not support the use of these interventions for improving cognition in older adults with subjective cognitive concerns. Trial Registration: ClinicalTrials.gov Identifier: NCT02665481.


Subject(s)
Cognitive Aging , Cognitive Dysfunction , Exercise Therapy , Meditation , Mindfulness , Aged , Female , Humans , Male , Cognition/physiology , Executive Function/physiology , Exercise/physiology , Exercise/psychology , Meditation/methods , Meditation/psychology , Mindfulness/methods , Memory, Episodic , Exercise Therapy/methods , Exercise Therapy/psychology , Cognitive Aging/physiology , Cognitive Aging/psychology , Healthy Lifestyle/physiology , Health Behavior/physiology , Stress, Psychological/physiopathology , Stress, Psychological/prevention & control , Stress, Psychological/therapy , Aged, 80 and over , Neuropsychological Tests , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/psychology , Cognitive Dysfunction/therapy , Magnetic Resonance Imaging
11.
Neurobiol Aging ; 119: 36-45, 2022 11.
Article in English | MEDLINE | ID: mdl-35964542

ABSTRACT

This study investigates whether tau has (i) an independent effect from amyloid-ß on changes in cognitive and functional performance and (ii) a synergistic relationship with amyloid-ß in the exacerbation of decline in aging Down syndrome (DS). 105 participants with DS underwent baseline PET [18F]-AV1451 and PET [11C]PiB scans to quantify tau deposition in Braak regions II-VI and the Striatum and amyloid-ß status respectively. Linear Mixed Effects models were implemented to assess how tau and amyloid-ß deposition are related to change over three time points. Tau was a significant independent predictor of cognitive and functional change. The three-way interaction between time, [11C]PiB status and tau was significant in the models of episodic memory and visuospatial cognition. Baseline tau is a significant predictor of cognitive and functional decline, over and above the effect of amyloid-ß status. Results suggest a synergistic relationship between amyloid-ß status and tau as predictors of change in memory and visuospatial cognition.


Subject(s)
Amyloid beta-Peptides , Cognitive Dysfunction , Down Syndrome , tau Proteins , Amyloid beta-Peptides/metabolism , Brain/metabolism , Cognition/physiology , Cognitive Aging/physiology , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/psychology , Down Syndrome/diagnostic imaging , Down Syndrome/metabolism , Down Syndrome/psychology , Humans , Positron-Emission Tomography/methods , tau Proteins/metabolism
12.
J Alzheimers Dis ; 85(4): 1767-1781, 2022.
Article in English | MEDLINE | ID: mdl-34974435

ABSTRACT

BACKGROUND: In healthy older adults, excess theta activity is an electroencephalographic (EEG) predictor of cognitive impairment. In a previous study, neurofeedback (NFB) treatment reinforcing reductions theta activity resulted in EEG reorganization and cognitive improvement. OBJECTIVE: To explore the clinical applicability of this NFB treatment, the present study performed a 1-year follow-up to determine its lasting effects. METHODS: Twenty seniors with excessive theta activity in their EEG were randomly assigned to the experimental or control group. The experimental group received an auditory reward when the theta absolute power (AP) was reduced. The control group received the reward randomly. RESULTS: Both groups showed a significant decrease in theta activity at the training electrode. However, the EEG results showed that only the experimental group underwent global changes after treatment. These changes consisted of delta and theta decreases and beta increases. Although no changes were found in any group during the period between the posttreatment evaluation and follow-up, more pronounced theta decreases and beta increases were observed in the experimental group when the follow-up and pretreatment measures were compared. Executive functions showed a tendency to improve two months after treatment which became significant one year later. CONCLUSION: These results suggest that the EEG and behavioral benefits of this NFB treatment persist for at least one year, which adds up to the available evidence contributing to identifying factors that increase its efficacy level. The relevance of this study lies in its prophylactic features of addressing a clinically healthy population with EEG risk of cognitive decline.


Subject(s)
Electroencephalography/instrumentation , Neurocognitive Disorders/diagnosis , Neurofeedback/physiology , Theta Rhythm/physiology , Aged , Cognitive Aging/physiology , Female , Follow-Up Studies , Healthy Volunteers , Humans , Male
13.
Hum Brain Mapp ; 43(3): 985-997, 2022 02 15.
Article in English | MEDLINE | ID: mdl-34713955

ABSTRACT

A common finding in the aging literature is that of the brain's decreased within- and increased between-network functional connectivity. However, it remains unclear what is causing this shift in network organization with age. Given the essential role of the ascending arousal system (ARAS) in cortical activation and previous findings of disrupted ARAS functioning with age, it is possible that age differences in ARAS functioning contribute to disrupted cortical connectivity. We test this possibility here using resting state fMRI data from over 500 individuals across the lifespan from the Cambridge Center for Aging and Neuroscience (Cam-CAN) population-based cohort. Our results show that ARAS-cortical connectivity declines with age and, consistent with our expectations, significantly mediates some age-related differences in connectivity within and between association networks (specifically, within the default mode and between the default mode and salience networks). Additionally, connectivity between the ARAS and association networks predicted cognitive performance across several tasks over and above the effects of age and connectivity within the cortical networks themselves. These findings suggest that age differences in cortical connectivity may be driven, at least in part, by altered arousal signals from the brainstem and that ARAS-cortical connectivity relates to cognitive performance with age.


Subject(s)
Arousal/physiology , Brain Stem/physiology , Cerebral Cortex/physiology , Cognitive Aging/physiology , Connectome , Default Mode Network/physiology , Nerve Net/physiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Brain Stem/diagnostic imaging , Cerebral Cortex/diagnostic imaging , Default Mode Network/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Nerve Net/diagnostic imaging , Young Adult
14.
Neurobiol Aging ; 109: 88-99, 2022 01.
Article in English | MEDLINE | ID: mdl-34700200

ABSTRACT

Longitudinal studies are essential to understand healthy and pathological neurocognitive aging such as Alzheimer's Disease, but longitudinal designs are rare in both humans and non-human primate models of aging because of the difficulty of tracking cognitive change in long-lived primates. Common marmosets (Callithrix jacchus) are uniquely suited for aging studies due to their naturally short lifespan (10-12 years), sophisticated cognitive and social abilities and Alzheimer Disease-like neuropathology. We report the first longitudinal study of cognitive aging in marmosets (N = 28) as they transitioned from middle- (∼5 years) to old age (∼9 years). We characterized aging trajectories using reversal learning with different stimuli each year. Marmosets initially improved on cognitive performance due to practice, but worsened in the final year, suggesting the onset of age-related decline. Cognitive impairment emerged earlier in females than males and was more prominent for discrimination than for reversal learning. Sex differences in cognitive aging could not be explained by differences in motivation or motor abilities, which improved or remained stable across aging. Likewise, males and females did not differ in aging trajectories of overall behavior or reactivity to a social stressor, with the exception of a progressive decline in the initiation of social behavior in females. Patterns of cognitive aging were highly variable across marmosets of both sexes, suggesting the potential for pathological aging for some individuals. Future work will link individual cognitive trajectories to neuropathology in order to better understand the relationships between neuropathologic burden and vulnerability to age-related cognitive decline in each sex.


Subject(s)
Aging/physiology , Aging/psychology , Callithrix , Cognitive Aging/physiology , Sex Characteristics , Animals , Behavior, Animal , Cognition , Female , Longitudinal Studies , Male , Models, Animal , Reversal Learning , Social Behavior , Time Factors
15.
J Gerontol B Psychol Sci Soc Sci ; 77(2): 261-271, 2022 02 03.
Article in English | MEDLINE | ID: mdl-33842969

ABSTRACT

OBJECTIVES: Understanding racial/ethnic disparities in late-life cognitive health is a public health imperative. We used baseline data from the Kaiser Healthy Aging and Diverse Life Experiences (KHANDLE) study to examine how age, education, gender, and clinical diagnosis, a proxy for brain health, are associated with cross-sectional measures of cognition in diverse racial/ethnic groups. METHODS: Comprehensive measures of cognition were obtained using the Spanish and English Neuropsychological Assessment Scales and the National Institutes of Health Toolbox Cognitive Health Battery in a sample of 1,695 KHANDLE participants (Asians 24%, Blacks 26%, Latinos 20%, Whites 29%). A 25% random subsample was clinically evaluated and diagnosed with normal cognition, mild cognitive impairment (MCI), or dementia. Cognitive test scores were regressed on core demographic variables and diagnosis in the combined sample and in multiple group analyses stratified by racial/ethnic group. RESULTS: Race/ethnicity and education were variably associated with test scores with strongest associations with tests of vocabulary and semantic memory. Older age was associated with poorer performance on all measures, and gender differences varied across cognitive tests. Clinical diagnosis of MCI or dementia was associated with average decrements in test scores that ranged from -0.41 to -0.84 SD, with largest differences on tests of executive function and episodic memory. With few exceptions, associations of demographic variables and clinical diagnosis did not differ across racial/ethnic groups. DISCUSSION: The robust associations of cognitive test results with clinical diagnosis independent of core demographic variables and race/ethnicity support the validity of cognitive tests as indicators for brain health in diverse older adults.


Subject(s)
Cognition , Cognitive Aging , Cognitive Dysfunction , Ethnicity , Executive Function , Aged , Cognitive Aging/physiology , Cognitive Aging/psychology , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/ethnology , Cross-Cultural Comparison , Cultural Diversity , Educational Status , Ethnicity/education , Ethnicity/psychology , Ethnicity/statistics & numerical data , Female , Healthy Aging/ethnology , Healthy Aging/psychology , Humans , Life Change Events , Male , Neuropsychological Tests/statistics & numerical data , United States/epidemiology
16.
J Gerontol B Psychol Sci Soc Sci ; 77(2): 351-361, 2022 02 03.
Article in English | MEDLINE | ID: mdl-33979436

ABSTRACT

OBJECTIVES: The present study examines the associations between mental, social, and physical demands of work and cognitive functioning among older adults in the United States. METHOD: Data from 3,176 respondents in the Health and Retirement Study were analyzed using growth curve modeling (2004-2014). The study investigated differences by gender, race, ethnicity, and education. RESULTS: Higher mental and social demands of work were associated with higher levels of initial cognitive functioning, but were not significantly associated with slower cognitive decline over time. Physical demands of work were negatively associated with initial cognitive functioning and were also marginally associated with a slower rate of decline in cognitive functioning going into older adulthood. In stratified analyses, results varied by sociodemographic characteristics. DISCUSSION: The results partially support the environmental complexity hypothesis and the productive aging framework in that higher mental and social demands and lower physical demands relate to better cognitive functioning at baseline, with the differences appearing stable throughout older adulthood. The stratified results shed light on addressing disparities in cognitive aging and work environments.


Subject(s)
Aging/psychology , Cognitive Aging/physiology , Cognitive Dysfunction , Job Description , Physical Functional Performance , Social Interaction , Aged , Cognition , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/psychology , Educational Status , Female , Humans , Intelligence , Male , Sociodemographic Factors , Work Performance
17.
J Gerontol B Psychol Sci Soc Sci ; 77(1): 94-103, 2022 01 12.
Article in English | MEDLINE | ID: mdl-33914083

ABSTRACT

OBJECTIVES: Arterial elasticity and physical fitness are 2 important cardiovascular health factors that influence cognition in older adults. Working memory capacity (WMC), a core component underlying cognitive aging across many cognitive domains, may be affected by individual differences in cardiovascular health in older adults. This study aims to identify in older adults: (a) separate and combined effects of these 2 cardiovascular health factors on WMC and (b) which of the 2 factors is more critical in influencing WMC. METHODS: WMC in 89 healthy older adults was assessed by 2 complex span tasks. Arterial elasticity was assessed by pulse pressure (PsP). Physical fitness was measured by an established proxy of VO2 max (MET). Effects of PsP and MET on WMC were evaluated via step-wise regressions. RESULTS: After controlling for age, sex, and education, PsP and MET were separately predictive of WMC in older adults. Together, the combined effect of PsP and MET was more predictive of WMC than fitness alone, but not more than PsP alone. Mediation analysis indicates that the relationship between MET and WMC was completely mediated by PsP. DISCUSSION: This study innovatively demonstrates that though arterial elasticity and physical fitness separately predict WMC, the former completely mediates the relationship between fitness and WMC. This suggests that biologically based cardiovascular health factors like arterial elasticity are crucial individual difference variables that should be measured and monitored in cognitive aging studies as well as in physical interventions that are designed to improve cognition in healthy aging.


Subject(s)
Aging/physiology , Memory, Short-Term/physiology , Physical Fitness/physiology , Vascular Stiffness/physiology , Aged , Aged, 80 and over , Cognitive Aging/physiology , Female , Heart Disease Risk Factors , Humans , Male , Middle Aged
18.
Neurobiol Aging ; 109: 176-191, 2022 01.
Article in English | MEDLINE | ID: mdl-34749169

ABSTRACT

Discovery research in rodent models of cognitive aging is instrumental for identifying mechanisms of behavioral decline in old age that can be therapeutically targeted. Clinically relevant behavioral paradigms, however, have not been widely employed in aged rats. The current study aimed to bridge this translational gap by testing cognition in a cross-species touchscreen-based platform known as paired-associates learning (PAL) and then utilizing a trial-by-trial behavioral analysis approach. This study found age-related deficits in PAL task acquisition in male rats. Furthermore, trial-by-trial analyses and testing rats on a novel interference version of PAL suggested that age-related impairments were not due to differences in vulnerability to an irrelevant distractor, motivation, or to forgetting. Rather, impairment appeared to arise from vulnerability to accumulating, proactive interference, with aged animals performing worse than younger rats in later trial blocks within a single testing session. The detailed behavioral analysis employed in this study provides new insights into the etiology of age-associated cognitive deficits.


Subject(s)
Behavior, Animal/physiology , Cognition/physiology , Cognitive Aging/physiology , Cognitive Aging/psychology , Neuropsychological Tests , Paired-Associate Learning/physiology , Touch/physiology , Age Factors , Animals , Cognitive Dysfunction/etiology , Cognitive Dysfunction/psychology , Conditioning, Operant/physiology , Disease Models, Animal , Male , Rats, Inbred F344
19.
Neurobiol Aging ; 109: 195-203, 2022 01.
Article in English | MEDLINE | ID: mdl-34775210

ABSTRACT

Brain age is a neuroimaging-based biomarker of aging. This study examined whether the difference between brain age and chronological age (brain-PAD) is associated with cognitive function at baseline and longitudinally. Participants were relatively healthy, predominantly white community-dwelling older adults (n = 531, aged ≥70 years), with high educational attainment (61% ≥12 years) and socioeconomic status (59% ≥75th percentile). Brain age was estimated from T1-weighted magnetic resonance images using an algorithm by Cole et al., 2018. After controlling for age, gender, education, depression and body mass index, brain-PAD was negatively associated with psychomotor speed (Symbol Digit Modalities Test) at baseline (Bonferroni p < 0.006), but was not associated with baseline verbal fluency (Controlled Oral Word Association Test), delayed recall (Hopkins Learning Test Revised), or general cognitive status (Mini-Mental State Examination). Baseline brain-PAD was not associated with 3-year change in cognition (Bonferroni p > 0.006). These findings indicate that even in relatively healthy older people, accelerated brain aging is associated with worse psychomotor speed, but future longitudinal research into changes in brain-PAD is needed.


Subject(s)
Aging/physiology , Aging/psychology , Brain/physiology , Cognition/physiology , Cognitive Aging/physiology , Cognitive Aging/psychology , Age Factors , Aged , Body Mass Index , Brain/diagnostic imaging , Brain/pathology , Diffusion Tensor Imaging , Educational Status , Female , Humans , Male , Neuroimaging , Psychomotor Performance , Reaction Time , Social Class
20.
J Neurosci ; 42(2): 288-298, 2022 01 12.
Article in English | MEDLINE | ID: mdl-34810231

ABSTRACT

Physical activity relates to reduced dementia risk, but the cellular and molecular mechanisms are unknown. We translated animal and in vitro studies demonstrating a causal link between physical activity and microglial homeostasis into humans. Decedents from Rush Memory and Aging Project completed actigraphy monitoring (average daily activity) and cognitive evaluation in life, and neuropathological examination at autopsy. Brain tissue was analyzed for microglial activation via immunohistochemistry (anti-human HLA-DP-DQ-DR) and morphology (% Stage I, II, or III), and synaptic protein levels (SNAP-25, synaptophysin, complexin-I, VAMP, syntaxin, synaptotagmin-1). Proportion of morphologically activated microglia (PAM) was estimated in ventromedial caudate, posterior putamen, inferior temporal (IT), and middle frontal gyrus. The 167 decedents averaged 90 years at death, two-thirds were nondemented, and 60% evidenced pathologic Alzheimer's disease (AD). Adjusting for age, sex, education, and motor performances, greater physical activity associated with lower PAM in the ventromedial caudate and IT. Relationships between physical activity and PAM in the ventromedial caudate or IT were particularly prominent in adults evidencing microinfarcts or AD pathology, respectively. Mediational analyses indicated that PAM IT mediated ∼30% of the relationships between (1) physical activity and synaptic protein in IT, and (2) physical activity and global cognition, in separate models. However, the size of the mediation depended on AD pathology ranging from >40% in adults with high AD burden, but <10% in adults with low AD burden. Lower microglial activation may be a pathway linking physical activity to age-related brain health in humans. Physical activity may promote AD-related synaptic and cognitive resilience through reduction of pro-inflammatory microglial states.SIGNIFICANCE STATEMENT Physical activity relates to better cognitive aging and reduced risk of neurodegenerative disease, yet the cellular and molecular pathways linking behavior-to-brain in humans are unknown. Animal studies indicate that increasing physical activity leads to decreased microglial activation and corresponding increases in synaptogenesis and neurogenesis. We objectively monitored physical activity (accelerometer-based actigraphy) and cognitive performances in life, and quantified microglial activation and synaptic markers in brain tissue at death in older adults. These are the first data supporting microglial activation as a physiological pathway by which physical activity relates to brain heath in humans. Although more interventional work is needed, we suggest that physical activity may be a modifiable behavior leveraged to reduce pro-inflammatory microglial states in humans.


Subject(s)
Aging/metabolism , Brain/metabolism , Cognitive Aging/physiology , Exercise/physiology , Microglia/metabolism , Synapses/metabolism , Adaptor Proteins, Vesicular Transport/metabolism , Aged , Aged, 80 and over , Female , Humans , Male , Nerve Tissue Proteins/metabolism , Qa-SNARE Proteins/metabolism , Synapsins/metabolism , Synaptophysin/metabolism , Synaptotagmins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...